GH
Guardant Health, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$157.26
−2.35%Margins
Gross margin
65.0%
EBITDA margin
-34.8%
EBIT margin
-39.7%
Net margin
-38.3%
FCF margin
-20.3%
203.5%
Return on equity
-23.7%
Return on assets
-31.9%
Return on invested capital
0.62x
Asset turnover
-$185.2M
Cash from operations
$7.85
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026